Lipo-B12 injections offer several benefits beyond just weight loss
Once the needle is in place, gently pull back on the plunger just a tiny bit
Future research should focus on refining these treatment modalities and expanding comparative studies to optimize B12 deficiency management strategies effectively
Adding MOTS-C to an AOD 9604 stack targets mitochondrial function and cellular energy metabolism
We use this combination to: Restore depleted NAD+ reserves Support natural B12-dependent metabolic functions Help patients avoid fatigue and energy crashes during NAD cycles Visit our regenerative wellness hub and see how these therapies work in synergy.

Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue